Alternative medicine in thyroid eye disease (TED)
Phase 3
Recruiting
- Conditions
- Thyroid eye disease.Thyrotoxicosis with diffuse goiter
- Registration Number
- IRCT20171207037777N1
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Thyroid eye disease with clinical activity score (CAS) equal to 1 or more
Exclusion Criteria
No consent
Poor coopration
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical activity of eye involvement. Timepoint: Before, 1 & 2 months after initiation of intervention. Method of measurement: Clinical evaluation.;Serologic level of IL2. Timepoint: Before and 2 months after initiation of intervention. Method of measurement: ELISA.;Serologic level of TNFa. Timepoint: Before and 2 months after initiation of intervention. Method of measurement: ELISA.
- Secondary Outcome Measures
Name Time Method